Literature DB >> 14634582

Vaginal cytokines in normal pregnancy.

Gilbert G G Donders1, Annie Vereecken, Eugene Bosmans, Bernard Spitz.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether the vaginal cytokine concentration varies during the course of uncomplicated pregnancy. STUDY
DESIGN: Prenatal visits of healthy women to University Hospital Gasthuisberg, Leuven, Belgium were considered. Cytokine levels in vaginal washings from 30 unselected healthy women with uncomplicated pregnancies were monitored during pregnancy and compared with those from 62 nonpregnant healthy control subjects. Exclusion criteria included bacterial vaginosis, moderate or severe aerobic vaginitis, Trichomonas vaginalis, Candida vaginitis (wet mount or culture), gonorrhea, and Chlamydia. Interleukin-6, interleukin-8, interleukin-1beta, interleukin-1-receptor antagonist, leukemia inhibitory factor, and tumor necrosis factor were measured. Nonparametric Kruskal-Wallis and Welch tests were used for univariate analysis, and the Spearman rank test was used for multivariate analysis.
RESULTS: Compared with concentrations in nonpregnant women, interleukin-1beta concentrations were similar, but interleukin-1-receptor antagonist production was depressed throughout pregnancy. Vaginal interleukin-6 and interleukin-8 were less often discovered during pregnancy than outside pregnancy and dipped significantly in the middle trimester, to rise again to prepregnancy levels in the third trimester. Leukemia inhibitory factor was lower during the beginning of pregnancy (P=.038) but otherwise did not differ from nonpregnant values throughout pregnancy nor did tumor necrosis factor. Sexual activity could not explain these findings.
CONCLUSION: Vaginal cytokine levels, especially interleukin-1 receptor antagonist, from pregnant women may differ from nonpregnant values; some levels, such as interleukin-6 and interleukin-8, may fluctuate during normal pregnancy. These spontaneous variations during pregnancy must be taken into account when mucosal immunologic responses to infection of the lower genital tract are being studied.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14634582     DOI: 10.1067/s0002-9378(03)00653-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  19 in total

Review 1.  Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis.

Authors:  Ronald F Lamont; Chia-Ling Nhan-Chang; Jack D Sobel; Kimberly Workowski; Agustin Conde-Agudelo; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2011-04-02       Impact factor: 8.661

2.  In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women.

Authors:  Brenna L Anderson; Mimi Ghosh; Christina Raker; John Fahey; Yan Song; Dwight J Rouse; Charles R Wira; Susan Cu-Uvin
Journal:  Am J Obstet Gynecol       Date:  2012-04-30       Impact factor: 8.661

3.  The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.

Authors:  Brenna L Hughes; Riana Dutt; Christina Raker; Melody Barthelemy; Richard M Rossoll; Bharat Ramratnam; Charles R Wira; Susan Cu-Uvin
Journal:  Am J Obstet Gynecol       Date:  2016-07-05       Impact factor: 8.661

4.  Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation.

Authors:  R N Fichorova; F Zhou; V Ratnam; V Atanassova; S Jiang; N Strick; A R Neurath
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 5.  Clinical parameters essential to methodology and interpretation of mucosal responses.

Authors:  Brenna L Anderson; Susan Cu-Uvin
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

6.  Repeated Measures of Cervicovaginal Cytokines during Healthy Pregnancy: Understanding "Normal" Inflammation to Inform Future Screening.

Authors:  Miatta A Buxton; Noemi Meraz-Cruz; Brisa N Sánchez; Betsy Foxman; Carina J Gronlund; Jorge Beltran-Montoya; Marisol Castillo-Castrejon; Marie S O'Neill; Felipe Vadillo-Ortega
Journal:  Am J Perinatol       Date:  2019-04-12       Impact factor: 1.862

7.  Increased Risk of HIV Acquisition Among Women Throughout Pregnancy and During the Postpartum Period: A Prospective Per-Coital-Act Analysis Among Women With HIV-Infected Partners.

Authors:  Kerry A Thomson; James Hughes; Jared M Baeten; Grace John-Stewart; Connie Celum; Craig R Cohen; Kenneth Ngure; James Kiarie; Nelly Mugo; Renee Heffron
Journal:  J Infect Dis       Date:  2018-06-05       Impact factor: 5.226

8.  Selecting anti-microbial treatment of aerobic vaginitis.

Authors:  Gilbert G G Donders; Katerina Ruban; Gert Bellen
Journal:  Curr Infect Dis Rep       Date:  2015-05       Impact factor: 3.725

9.  Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.

Authors:  Jordan K Kyongo; Tania Crucitti; Joris Menten; Liselotte Hardy; Piet Cools; Johan Michiels; Sinead Delany-Moretlwe; Mary Mwaura; Gilles Ndayisaba; Sarah Joseph; Raina Fichorova; Janneke van de Wijgert; Guido Vanham; Kevin K Ariën; Vicky Jespers
Journal:  Clin Vaccine Immunol       Date:  2015-03-11

10.  Pregnancy-induced changes in immune protection of the genital tract: defining normal.

Authors:  Brenna L Anderson; Hector Mendez-Figueroa; Joshua D Dahlke; Christina Raker; Sharon L Hillier; Susan Cu-Uvin
Journal:  Am J Obstet Gynecol       Date:  2013-01-10       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.